APP and Alzheimer disease: Since the description more than two decades ago of the pioneering yeast (S. cerevisiae) AD model, so-called “humanized yeast model systems” heterologically expressing mammalian Aβ and tau have been constructed for gaining new insights into APP in vivo processing, Aβ localization, oligomerization, and toxicity.